Rhinitis, Allergic clinical trials
The registry lists 717 studies for Rhinitis, Allergic across more than 10 countries. 94 are recruiting or about to start. 518 of them are mainly about Rhinitis, Allergic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 3 narrower conditions too, such as Rhinitis, Allergic, Seasonal: 1,192 studies, 125 open.
ClinicalTrials.gov finds 1,281 studies for Rhinitis, Allergic. How that becomes 717 here
This page counts the studies the registry files under Rhinitis, Allergic, and those it files under no condition that list Rhinitis, Allergicthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 1,281Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −458Filed under a narrower condition, counted on its own pageRhinitis, Allergic, Seasonal 304 · Rhinitis, Allergic, Perennial 122 · Dust Mite Allergy 29
- −9List Rhinitis, Allergic as a condition, but the registry did not file them under itMost often written as “Rhinitis, Allergic, Perennial and Seasonal” (2), “Allergic Rhinitis Due to Grass Pollens” (2), and “Allergic Rhinitis Due to House Dust Mite” (2). The registry filed them under other conditions only, most often Rhinitis (5) and Hypersensitivity (3).
- −97Match it another way60 name it in the title, 3 in a keyword, and 34 by a synonym or other text the search reads.
- 717The count on this page35 of them list Rhinitis, Allergic in their own words; the registry filed them under no condition.
Get an email when these change. Save the Rhinitis, Allergic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
GlaxoSmithKline (34) · Organon and Co (21) · ALK-Abelló A/S (19) · AstraZeneca (11) · HAL Allergy (10) · Chulalongkorn University (10) · University of Chicago (10) · Beijing Tongren Hospital (9)
What is being tested here
Drugs under test in Rhinitis, Allergic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Loratadine | 2 | 2 | 8 |
| Ornidazole | 2 | 0 | 2 |
| Montelukast | 1 | 3 | 13 |
| Levocetirizine | 1 | 5 | 12 |
| Mometasone Furoate | 1 | 5 | 11 |
| Desloratadine | 1 | 6 | 8 |
| Stapokibart | 1 | 1 | 3 |
| Diphenhydramine | 1 | 0 | 3 |
| Dermatophagoides farinae | 1 | 1 | 3 |
| Ascorbic Acid | 1 | 0 | 2 |
Drug classes tested here Antihistamines 3 open · Corticosteroids 1 open · Bronchodilators 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites · Phase 3 · Inmunotek S.L.
- Dec 2026Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) · Phase 3 · Chinese University of Hong Kong
- Oct 2027Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis · Phase 3 · Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
- Nov 2026Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy · The First Affiliated Hospital with Nanjing Medical University
- Nov 2026Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal Obstruction · Laboratoires Gilbert
- Dec 2026Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) · Dr. Anne Ellis
- Dec 2026Validating Blinding Maintenance of a Sham-Sensitization Control Design for Sensitization Acupuncture Trials · Jiangxi University of Traditional Chinese Medicine
- Dec 2026The Effect of Oral Probiotics on Allergic Rhinitis Symptoms and the Quality of Life · Glac Biotech Co., Ltd
- Dec 2026Sphenopalatine Ganglion Acupuncture for Allergic Rhinitis · Zhongshan Torch Development Zone People's Hospital
- Dec 2026Study of the Effects and Mechanisms of Yeast Postbiotics on Persistent Allergic Rhinitis Symptoms · LanZhou University
Who these studies take
Of the 54 Rhinitis, Allergic studies recruiting now, 11 (20%) set no upper age limit and 38 (70%) stop at 75 or younger. 22 (41%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 13 (24%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 12 (22%) | 12 (22%) |
| 18 | 45 (83%) | 45 (83%) |
| 30 | 49 (91%) | 49 (91%) |
| 40 | 48 (89%) | 48 (89%) |
| 50 | 47 (87%) | 47 (87%) |
| 65 | 44 (81%) | 44 (81%) |
| 75 | 21 (39%) | 21 (39%) |
| 85 | 13 (24%) | 13 (24%) |
Across all 717 studies, recruiting or not: 74% stop at 75 or younger and 66% at 65; 36% take children; <1% are for women only and 2% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Rhinitis, Allergic studies take
Of 41 phase 3 interventional studies under Rhinitis, Allergic, half reached primary completion within 13 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 5 mo3–16 · 25 studies | — | — |
| Phase 2 | 11 mo4–29 · 31 studies | — | — |
| Phase 3 | 13 mo6–35 · 41 studies | 11 mo5–41 · 31 studies | — |
| Phase 4 | 10 mo4–38 · 34 studies | — | — |
| Interventional, no phase | 11 mo4–27 · 87 studies | — | 13 mo6–28 · 66 studies |
| Observational | 21 mo12–29 · 49 studies | — | 19 mo11–37 · 36 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 12, 2026.
Newly registered4
- Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.Oct 29, 2026NCT07904052
- Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063.Oct 29, 2026NCT07904195
- Efficacy and Safety of Xinyi Powder in Patients With Allergic Rhinitis and the Lung Deficiency and Cold SyndromeOct 27, 2026NCT07899515
- Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University HospitalOct 26, 2026NCT07896291
Studies
Recruiting first, then most recently updated. Showing 50 of 717. Browse all 717 → or search them.
- Safety and Tolerability of Fluticasone Propionate 10% Nasal Insert in Participants With Chronic Allergic RhinitisNot yet recruitingNCT07918404Phase 1
- Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063.RecruitingNCT07904195Phase 32 countries
- Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.RecruitingNCT07904052Phase 32 countries
- Allergy, Asthma, and Atopic Eczema in FinlandEnrolling by invitationNCT063309741 country
- Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University HospitalNot yet recruitingNCT078962911 country
- A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-UpRecruitingNCT067324141 country
- Post-market Clinical Follow-up Study of an Isotonic Saline Solution for the Relief of Nasal Congestion in Infants and ToddlersNot yet recruitingNCT072572241 country
- Validating Blinding Maintenance of a Sham-Sensitization Control Design for Sensitization Acupuncture TrialsNot yet recruitingNCT07868224Not applicable1 country
- Investigating Nasal and Ocular Immune Response to Conjunctival Allergen ExposureRecruitingNCT078016251 country
- Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic RhinitisRecruitingNCT07588672Not applicable1 country
- A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 YearsNot yet recruitingNCT07835074Phase 3
- Rupatifen Fumarate Capsules in Patients With Seasonal Allergic RhinitisRecruitingNCT07711262Phase 31 country
- Sphenopalatine Ganglion Acupuncture for Allergic RhinitisNot yet recruitingNCT07784491Not applicable1 country
- Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"RecruitingNCT05494346Not applicable1 country
- Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal ObstructionRecruitingNCT065802101 country
- Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)RecruitingNCT06608017Phase 2/31 country
- Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic RhinitisRecruitingNCT06436534Not applicable1 country
- Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish PracticeRecruitingNCT07651891Phase 41 country
- EFFECT OF AYURVEDA TREATMENT IN ALLERGIC RHINITISNot yet recruitingNCT07626099Not applicable
- Observational Study of RHINOSEDAL in Acute Nasal ObstructionNot yet recruitingNCT076205221 country
- Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision AidRecruitingNCT07435714Not applicable1 country
- EmoTIChealth: Promoting Adolescent Health Through a Serious Game.RecruitingNCT07212530Not applicable1 country
- Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency SyndromeNot yet recruitingNCT07540351Phase 1
- Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic RhinitisNot yet recruitingNCT07532993Phase 41 country
- Effects of Adenoidectomy on Symptoms and IgE Levels in Children With ARNot yet recruitingNCT07527260Not applicable1 country
- Dietary Intervention on AtopyRecruitingNCT06547372Not applicable1 country
- Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme ProjectRecruitingNCT07419230Not applicable1 country
- Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust MitesNot yet recruitingNCT07475715Phase 21 country
- Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without AsthmaRecruitingNCT06960382Phase 1/21 country
- The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or AsthmaRecruitingNCT074523801 country
- Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With AsthmaNot yet recruitingNCT07453771Not applicable1 country
- Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal StudyRecruitingNCT066237991 country
- Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)Enrolling by invitationNCT06603935Not applicable1 country
- Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or DfRecruitingNCT07348302Phase 34 countries
- Implementation of an Allergic Rhinitis Severity Questionnaire in ENT ConsultationsRecruitingNCT073159451 country
- A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis SymptomsNot yet recruitingNCT07294326Phase 4
- ClimAIr: AI to Assess the Impact of Pollution and Climate on Respiratory Health in EuropeNot yet recruitingNCT07107009
- Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled TrialNot yet recruitingNCT07269509Not applicable1 country
- Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal SymptomsRecruitingNCT07262450Not applicable1 country
- Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA®) in House Dust Mite Allergic Rhinitis- ACARAY StudyNot yet recruitingNCT07196527Not applicable
- Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With AsthmaRecruitingNCT07168473Phase 31 country
- Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic RhinitisRecruitingNCT07115342Not applicable1 country
- A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair AllergiesEnrolling by invitationNCT07114133Not applicable1 country
- Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen AllergyRecruitingNCT071103111 country
- Study of the Effects and Mechanisms of Yeast Postbiotics on Persistent Allergic Rhinitis SymptomsNot yet recruitingNCT07079748Not applicable1 country
- Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesRecruitingNCT04435990Phase 31 country
- Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.RecruitingNCT04898283Phase 31 country
- Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive PollenRecruitingNCT04891237Phase 31 country
- Efficacy and Safety of Arbidol in the Treatment of Allergic RhinitisRecruitingNCT06462417Not applicable1 country
- Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic SubjectsNot yet recruitingNCT064592191 country